BSEShelter Pharma Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 26 Jun, 2025 · 12:41 IST

Raising of Fund through issue of Convertible warrants

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+10.5%Reaction day
₹39.60
prior close
₹41.78
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.0%+10.4% vs market
Pharmaceuticals peers, median of 151sector-0.2%+10.7% vs sector

On the reaction day the stock moved 10.4 pts more than Nifty Microcap 250 and 10.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+10.5+0.0+10.4-0.2+10.7
Next day
+14.8+0.5+14.2+0.3+14.5
2d
+13.6+1.4+12.2+1.2+12.4
3d
+13.8+1.5+12.3+0.9+12.8
4d
+5.8+1.3+4.5+1.0+4.8
5d
+5.2+1.4+3.8+1.3+3.9
1w
+3.5+1.3+2.2+0.8+2.7
15d
+8.4+3.7+4.6+3.7+4.6
1m
+12.4-0.8+13.1+0.6+11.8
2m
+19.7-2.8+22.4-3.6+23.3
3m
+11.1-2.9+14.0-2.9+14.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shelter Pharma Ltd has announced plans to raise funds by issuing convertible warrants to investors. Convertible warrants are financial instruments that can be converted into equity shares of the company at a later date at a pre-agreed price. The company has not yet disclosed the total amount it intends to raise, the number of warrants to be issued, or the conversion price. This is a common method used by listed companies to bring in capital without an immediate equity dilution, since conversion happens at a later stage. Further details such as allotment ratio, issue price, and eligible investors are expected in follow-up filings.

Likely market impact

For existing shareholders, this signals potential equity dilution in the future once the warrants are converted into shares. The market may react based on the size of the issue and the identity of the allottees, but without further details, the immediate impact on the stock is uncertain.